Stockwinners Market Radar for June 20, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:00 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Barnes & Noble Education (BNED) up 7.3%... Micron (MU) up 2.8%... Steelcase (SCS) up 1.3%. ALSO HIGHER: Lumentum (LITE) up 2.7% after Goldman Sachs upgrade... HP Inc (HPQ) up 2.1% after announcing $4B stock buyback... Thor Industries (THO) up 1.7% after update on stock repurchase... Corning (GLW) up 1.4% after Goldman Sachs upgrade. DOWN AFTER EARNINGS: American Outdoor Brands (AOBC) down 4.4%. ALSO LOWER: Limoneira (LMNR) down 13.9% after equity offering... Veritone (VERI) down 5.1% after equity offering... Trupanion (TRUP) down 4.8% after filing mixed shelf... Arris International (ARRS) down 2.0% after Goldman Sachs downgrade... Wix.com (WIX) down 1.6% after equity offering.

18:04 EDT North American Construction Group awarded $160M contract from oil sands customer - North American Construction Group announced the successful negotiation of a second term contract related to the recently notified extension to a key Master Services Agreement, with a major oil sands customer. The work-scope involves mine reclamation services and has duration of three years, commencing with this winter season. The value of this incremental backlog is expected to be around $160M.

17:34 EDT Buenaventura discloses Sumitomo Corp purchased 5% stake in Minera Yanacocha - Compania de Minas Buenaventura announced the purchase by Sumitomo Corporation of a 5% stake in Minera Yanacocha S.R.L. Under this transaction between Buenaventura, Newmont and Sumitomo, Sumitomo takes the place of the International Finance Corporation as a five percent minority shareholder in Yanacocha in exchange for approximately $48M.

17:16 EDT Cooper-Standard announces $150M share repurchase plan - Cooper-Standard Holdings announced that on June 14, its board approved a share repurchase program authorizing the company to repurchase, in the aggregate, up to $150M of its outstanding common stock. The share repurchase program, which is effective as of November 6, replaces the previous $125M authorization to repurchase shares approved in March 2016. Of the $45.3M remaining from the previous authorization as of December 31, 2017, the company utilized $43.5M during Q2 of 2018 through open market and accelerated share repurchases.

17:05 EDT International Paper CFO Glenn Landau to leave, Timothy Nicholls to succeed - International Paper announced that Timothy Nicholls has been appointed senior VP and CFO, succeeding Glenn Landau who is leaving the company for personal reasons. Nicholls, who currently serves as senior VP industrial packaging the Americas, previously served as CFO of the company from December 2007 through November 2011.

17:00 EDT Micron Q3 storage business unit revenue down since Q2 and year-over-year - Micron Q3 storage business unit revenue down was 9% from Q2 and down 13% from last year's Q3. Reflects shift of NAND supply to High-Value mobile managed NAND. Information from company's investor presentation.

16:51 EDT Corvex Management lowers stake in Energen to 7.9% from 8.7% - As previously disclosed, on May 20, 2018, the Corvex Parties and the Icahn Group entered into the Purchase Agreement pursuant to which the Icahn Group agreed to purchase 750,000 Shares of the Issuer at a price of $64.84 per Share from the Corvex Parties, with the transaction to settle on the earlier of July 18, 2018 or one business day following the receipt by the Icahn Group of clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. On June 19, 2018, the Icahn Group received HSR clearance and the transaction pursuant to the Purchase Agreement settled on June 20, 2018.

16:45 EDT Granite Point Mortgage raises a quarterly dividend to 40c from 38c - Granite Point Mortgage Trust declared a quarterly dividend of 40c per share of common stock for the second quarter of 2018. This dividend is payable on July 18 to common stockholders of record at the close of business on July 2.

16:37 EDT Supervalu enters reseller agreement with Instacart - SUPERVALU has entered into a reseller agreement with Instacart, creating a new professional services offering and expanding the company's digital capabilities. The agreement allows SUPERVALU to offer the benefits of online shopping and delivery services to more than 3,000 independent retail stores supplied by SUPERVALU as well as other retailers across the U.S. in the over 240 metro areas where Instacart operates. Instacart's turn-key solution provides same-day grocery delivery or in-store pickup services to retailers through the use of personal shoppers who pick and deliver orders to consumers in as little as one hour. The e-commerce platform provided by Instacart requires limited capital investment and, when combined with SUPERVALU's digital marketing services, will provide SUPERVALU retailers with the capabilities to service more customers, more often, without POS integrations or additional labor costs. The Instacart and SUPERVALU agreement offers significant benefits through contracted pricing, placement on Instacart.com, and marketing expertise and support for retailers offering e-commerce to consumers.

16:33 EDT Kearny Financial appoints Eric Heyer as COO and other namagement changes - Kearny Financial promoted Eric Heyer to Senior Executive VP and COO. Heyer has served as the company's Executive VP and CFO since April 2014, after previously serving as Senior VP and CFOOfficer from April 2011 to April 2014. Heyer will assume the responsibilities of William Ledgerwood, Senior Executive VP and COO, who announced his retirement effective December 31. Heyer will begin his new position effective July 1, with Ledgerwood supporting this transition through the end of 2018. Additionally, Keith Suchodolski has been promoted to Executive VP and CFO effective July 1. Suchodolski joined the Bank in 2013 and currently holds the position of Senior VP Corporate Finance and Chief Accounting Officer.

16:32 EDT Norwegian Cruise Line appoints Russell Galbut as new board chairman - Norwegian Cruise Line Holdings announced at its 2018 annual general meeting that the company's board has appointed Mr. Russell W. Galbut, an independent director of the Board, as Chairman. In addition, the shareholders of the Company have elected retired U.S. Coast Guard Rear Admiral Mary E. Landry as a new independent director. Effective June 20, 2018, Mr. Galbut succeeds Mr. Walter Revell, who stepped down from Norwegian's Board after serving as Chairman for the past three years and on the Board for over two decades.

16:30 EDT Micron says DRAM made up 71% of Q3 revenue - Says trade NAND made up 25% of Q3 revenue. Says expects to further reduce debt position by about $2B in Q4. Seess transitioning from debt reduction to capital returns in fiscal 2019 via share repurchases. Says achieved 64L NAND production output crossover in Q3. Says expects to have 96L NAND production shipments in the second half of the year. Sees good progress on 4th generation NAND development. Says on track to achieve 1Xnm DRAM production output crossover in the second half of the year. Says on track to begin 1Ynm DRAM production shipments in the second half of the year. Says 1Znm and 1anm development programs on the way. Comments taken from slides to be presented on Q3 earnings conference call.

16:21 EDT Albemarle signs hydrocracking agreement with Sinopec Catalyst and FRIPP - Albemarle has signed a Heads of Agreement in the field of heavy feedstock hydrocracking for the company's catalysts business unit. Sinopec Catalyst Co., Sinopec Fushun Research Institute of Petroleum and Petrochemicals, and Albemarle's catalysts business are combining strengths by cooperating in the field of catalytic hydrocracking. The cooperation will be worldwide and on a non-exclusive basis. Albemarle, SCC and FRIPP will combine forces for supplying hydrocracking pre-treat and hydrocracking catalysts and expertise.

16:19 EDT Reata Pharmaceuticals initiates phase 1 trial of RTA 1701 - Reata Pharmaceuticals announced the initiation of a Phase 1 clinical trial of Reata's RTA 1701, a highly selective and orally bioavailable allosteric RORgammat inhibitor. This Phase 1, first-in-human study is evaluating the safety and pharmacokinetics of RTA 1701 in healthy volunteers and assessing ex vivo suppression of IL-17A secretion. Initial results are expected in the first half of 2019. In preclinical studies, RTA 1701 exhibited potent inhibition of the expression of IL-17A, a key cytokine involved in the development and progression of autoimmune diseases. In a two-week study in non-human primates, RTA 1701 produced significant suppression of ex vivo stimulation of IL-17A secretion in whole blood in both a dose- and concentration-dependent manner, with significant effects observed as early as 24 hours after the first administration. In this non-human primate study, RTA 1701 also demonstrated dose-dependent systemic exposure over a broad dose range and a pharmacokinetic profile that supports once-daily oral administration. Other in vitro studies demonstrated that expression of IL-17A was significantly reduced by RTA 1701 treatment in blood samples from patients with rheumatoid arthritis and psoriasis. Additionally, RTA 1701 has demonstrated significant efficacy after oral dosing in rodent models of rheumatoid arthritis and multiple sclerosis. RTA 1701 was discovered by Reata, who holds global rights for the asset.

16:18 EDT Vicon Industries receives NYSE American notification of noncompliance - On June 14, 2018, Vicon Industries, Inc. received a letter from NYSE American LLC stating that the company is not in compliance with the stockholders' equity continued listing standards set forth in Section 1003aii of the NYSE American Company Guide. In order to maintain its listing, the company must submit a plan of compliance by July 16, 2018 addressing how it intends to regain compliance with Section 1003aii of the Company Guide by December 16, 2019. The company's management is pursuing options to address the deficiency and intends to submit a compliance plan on or before the deadline set by the Exchange.

16:17 EDT NCI Building CFO Mark Johnson retires, Bradley Little named interim CFO - NCI Building Systems announced that Mark Johnson, the company's Executive Vice President, CFO and Treasurer has informed the Board of Directors of his retirement from his position with the company, effective June 29. As the company continues its search for a new CFO, Bradly Little, Vice President, Finance and Chief Accounting Officer, will serve as NCI's interim CFO and Treasurer effective June 29.

16:16 EDT Micron down over 1.5% afterhours following Q3 earnings

16:13 EDT Micron sees 'healthy industry fundamentals' in Q4 - The company said in its earnings release, "Micron delivered record results in financial performance for the third fiscal quarter, supported by strong execution and ongoing secular demand trends. We strengthened our competitive position and grew our revenue across virtually all of our high-value product segments. We set new records for revenue in SSDs, Mobile Managed NAND and Automotive solutions along with Cloud/Enterprise and Graphics DRAM Memory. We see ongoing momentum and healthy industry fundamentals in the fourth quarter to close out an exceptionally strong fiscal 2018."

16:06 EDT Galapagos NV increases share capital through warrant exercises - Galapagos NV announces a share capital increase arising from warrant exercises.Galapagos issued 102,801 new ordinary shares on 20 June, for a total capital increase of EURO$1,337,017.89.Pursuant to the warrant exercise program of Galapagos' executive committee, executive committee members automatically are committed to exercise a minimum number of warrants, subject to certain conditions. In accordance with the rules of this program, CEO Onno van de Stolpe exercised 15,000 warrants. Three other executive committee members exercised an aggregate number of 45,000 warrants. In addition to Onno van de Stolpe, one other member of our board of directors exercised an aggregate number of 5,400 warrants. In accordance with Belgian transparency legislation[1], Galapagos notes that its total share capital currently amounts to EURO$277,679,082.33, the total number of securities conferring voting rights is 51,337,763, which is also the total number of voting rights, and all securities conferring voting rights and all voting rights are of the same category. The total number of rights to subscribe to not yet issued securities conferring voting rights is 3,557,822, which equals the total number of voting rights that may result from the exercise of these warrants. Galapagos does not have any convertible bonds or shares without voting rights outstanding.

16:03 EDT HP Enterprise Pointnext capacity hastens transition to memory-driven computing - Hewlett Packard Enterprise announced the launch of an incubation practice with specialized skills for solving big data problems through Memory-Driven Computing, leveraging the expertise of Hewlett Packard Labs and HPE Pointnext. Through HPE Pointnext advisory and professional services capabilities, the company will work with leading-edge customers to explore Memory-Driven Computing applications and deliver proofs-of-concept that will demonstrate dramatic performance gains never before possible.Designed to dramatically improve performance and efficiency and unleash a new era of intellectual discovery and business opportunities, Memory-Driven Computing is a new computing architecture that puts memory, not processing, at the center of the computing platform. Hewlett Packard Labs is developing the breakthrough technology innovations needed to enable Memory-Driven Computing as part of The Machine research project. Using the new architecture, organizations will be able to process vast amounts of data significantly faster and reduce the time to extract insight, from days to hours, hours to minutes, minutes to seconds, ultimately delivering real-time intelligence."We believe that all data is valuable. Our vision for Memory-Driven Computing is to enable customers to capture, keep and refine every last bit of their data, up to 10,000 times faster than yesterday's solutions," said Beena Ammanath, global vice president, Artificial Intelligence, Data and Innovation, HPE. "The introduction of HPE Pointnext capabilities for Memory-Driven Computing will accelerate our ability to bring Memory-Driven Computing technologies to our customers and help them solve some of their most complex problems and more quickly than ever before."

16:01 EDT Exxon Mobil Singapore butyl and resin plants start production - ExxonMobil said it has started production of hydrogenated hydrocarbon resin and halobutyl rubber at its integrated manufacturing complex in Singapore, the company's largest integrated refining and petrochemical complex in the world. ExxonMobil's new EscorezTM hydrogenated hydrocarbon resins plant will be the world's largest with a capacity of 90,000 tonnes per year, and will meet long-term demand growth for hot-melt adhesives used in packaging or baby diapers. The new 140,000-tonnes-per-year butyl plant will produce premium halobutyl rubber used by manufacturers for tires that better maintain inflation to improve fuel economy.

15:43 EDT Novo Nordisk reports headline results of oral semaglutide trials - Novo Nordisk announced the "successful" completion and headline results of the phase 3a trials PIONEER 4 comparing oral semaglutide as a treatment for adults with type 2 diabetes to Victoza and placebo, and PIONEER 7 comparing oral semaglutide as a treatment for adults with type 2 diabetes to sitagliptin 100 mg. Oral semaglutide is a new GLP-1 analogue taken once daily as a tablet. PIONEER 4 achieved its primary objective according to the primary statistical approach by demonstrating a non-inferior reduction in HbA1c and statistically significant and superior weight loss at 26 weeks with oral semaglutide compared to Victoza. Furthermore, oral semaglutide provided statistically significant and superior reductions in HbA1c and weight compared to placebo. PIONEER 7 achieved its primary objective according to the primary statistical principle by demonstrating that oral semaglutide was statistically significant and superior to sitagliptin 100 mg in the proportion of people achieving the American Diabetes Association treatment target of HbA1c below 7% at week 52. Oral semaglutide also demonstrated statistically significant and superior reductions in body weight versus sitagliptin, the company said.

15:35 EDT DoD completes Verizon-led unified communications integration - Verizon Enterprise Solutions announced that the U.S. Department of Defense has taken a significant step forward in its Everything Over IP initiative by migrating one if its key agencies to a unified communications platform. In doing so, the DoD replaced two legacy systems with a single next generation solution. Federal IT modernization is top of mind for most agencies. For many, it requires updating legacy or aging communications systems because they are are increasingly difficult to maintain and can have limited features and devices for effective collaboration and communication. This migration process and initial deployment, led by Verizon, and with the joint efforts of technology lead, Ribbon Communications; integration collaborator, Black Box; and engineering lead, Visioneering; was designed for rapid execution, with little operational disruption, to enable members of every component to leverage secure real-time UC technology. The agency can seamlessly integrate voice, video, instant messaging, presence and conferencing, creating a platform for constituents and federal employees to efficiently communicate across channels and embrace a more digital and customized end-user experience.

14:52 EDT New York AG, Governor sue 3M, others over use of hazardous firefighting foam - New York Attorney General Barbara D. Underwood and Governor Andrew M. Cuomo announced a lawsuit against 3M and five other companies to recoup at least $38M in costs incurred by the State in cleaning up environmental contamination caused by toxic chemicals in their products. The suit alleges that the use of firefighting foams made by the companies at military and civilian airports in Newburgh and New Windsor, Southampton, Plattsburgh, and Rome resulted in extensive contamination of soil, fish, and water by perfluorooctane sulfonic acid/perfluoroctane sulfonate and perfluorooctanoic acid/perflurooctanoate. The suit charges that the companies are liable under state law for the contamination caused by their products, based on their conduct manufacturing and marketing products with defective designs, inadequate warning of product dangers, and the creation of a public nuisance. The six companies named in the suit - 3M Company, Tyco Fire Products LP, Chemguard, Inc., Buckeye Fire Equipment Company, National Foam, Inc., and Kidde-Fenwal, Inc. - allegedly designed, manufactured, marketed, and sold foams used for firefighting and firefighting training at Stewart Air National Guard Base and Stewart International Airport, Francis S. Gabreski Airport, former Plattsburgh Air Force Base, and former Griffiss Air Force Base. These firefighting foams contained PFOA or PFOS or compounds that degrade into PFOA and/or PFOS. The foams contained these chemicals to aid in extinguishing flammable liquid fires common to aircraft-related accidents. Reference Link

14:05 EDT American says PSA stabilized systems Tuesday, sees close to normal ops Thursday - In an update posted to its website, American Airlines stated: "PSA Airlines stabilized its computer systems on Tuesday morning. Since then, team members have been working nonstop to reposition crews and aircraft so the airline can get back to a normal schedule. PSA anticipates running approximately 70% to 80% of its schedule today and close to a normal operation on Thursday. We apologize to our customers for this serious disruption and we have been working around the clock to rebook passengers as quickly as possible. Approximately 2,750 PSA flights have been cancelled since last Thursday."

13:26 EDT Starbucks senior unsecured ratings downgraded by Moody's - Moody's downgraded Starbucks' senior unsecured ratings to Baa1 from A3. In addition, Moody's affirmed the company's short term commercial paper rating at Prime-2. The outlook is negative. The downgrade was prompted by Starbucks' decision to "materially increase debt to support returns to shareholders," the rating agency said in a statement. Shareholder returns are now targeted at $25B -- up from $15B in November 2017 -- over the three year period from 2018 through 2020, it added. "This change in policy will be partially funded with additional debt and result in a deterioration in credit metrics that are more representative of the revised ratings," said Moody's. "The material increase in Starbuck's fixed shareholder return target will result in significantly higher debt levels and weaker credit metrics at a time of operating challenges" stated Moody's Senior Credit Officer Bill Fahy." We estimate that the additional debt needed to fund the proposed shareholder returns will result in leverage exceeding 2.8 times and retained cash flow to total debt of around 20%. "In addition, we remain concerned that Starbucks willingness to curtail shareholder returns in the event operating results fall short of expectations remains uncertain and could lead to a further deterioration in credit metrics," added Fahy.

13:15 EDT Vicon Industrial trading halted, news pending

12:52 EDT Winnebago results spark buying in RV names - Shares of recreational vehicle maker Winnebago (WGO) are moving higher on Wednesday after reporting third quarter financial results that beat estimates. The RV maker reported Q3 earnings per share of $1.02 on revenue of $562.3M, beating analysts' consensus estimates of 91c and $540.59M, respectively. INFLATIONARY PRESSURES: Gross profit margin was 15.2% in the quarter, an increase of 30 basis points versus14.9% last year, driven by the continuation of accelerated growth in the Towable segment. "While inflationary pressures have been building and will continue to do so, our teams are working hard to mitigate these through numerous cost savings initiatives and select price increases where necessary. Our new product launches across both segments are performing well, driving healthy backlog increases, and we remain comfortable with our current dealer inventory levels which are supported by our strong retail performance and increases in market share," said chief executive officer Michael Happe. Earlier this month, Winnebago competitor Thor (THO) said its overall gross profit margins declined to 14.1% in Q3 compared to 14.6% in the prior-year period, reflecting increased costs primarily associated with warranty expenses, including expenses associated with an extended warranty program on certain products, as well as slightly higher labor and material costs, while Q3 net income was enhanced by Trump tax cuts. "Our third quarter results reflect another period of solid growth of both sales and earnings," said Thor CEO Bob Martin at the time. PRICE ACTION: Shares of Winnebago are up about 12% to $45.15 in afternoon trading. RV PEERS FOLLOW HIGHER. Shares of RV peer Thor are trading higher as well as related companies, including Camping World Holdings (CWH), Polaris Industries (PII) and REV Group (REVG).

12:30 EDT SWEPCO says LPSC approves proposed Wind Catcher Energy Connection project - Southwestern Electric Power Co., or SWEPCO, an American Electric Power company, announced that the Louisiana Public Service Commission has approved the proposed Wind Catcher Energy Connection project. The $4.5B project includes the acquisition of a 2,000-megawatt wind farm under construction in the Oklahoma Panhandle, and construction of an approximately 350-mile dedicated power line that will carry the wind energy to the Tulsa area, where the existing grid will deliver it to customers. SWEPCO will own 70% of the project. SWEPCO's sister company, Public Service Company of Oklahoma, will own 30%. SWEPCO anticipates the project will save its customers more than $4B over the 25-year life of the wind farm, compared to the projected costs of buying power on the open market. Wind Catcher is the largest single-site wind project in the United States. The wind farm is under development by Invenergy in Cimarron and Texas counties in the Oklahoma Panhandle. SWEPCO and PSO will purchase the facility at completion, which is scheduled for the fourth quarter of 2020.

12:09 EDT Altice says U.S .mobile service available in 2019,names Jean-Charles Nicolas SVP - Altice USA announces that Jean-Charles Nicolas has joined the company as SVP, Altice Mobile. In this newly created role, Nicolas will lead the development, launch, and ongoing market strategy for Altice USA's mobile service, which is expected to be available by 2019. Nicolas will be responsible for the end-to-end mobile customer experience, including operations, marketing, sales, and customer care. Nicolas reports to Hakim Boubazine, Altice USA's Co-President and Chief Operating Officer. "Jean-Charles brings with him more than 20 years of experience in the mobile communications industry, and we are pleased to have him join us in the U.S. as we prepare to launch our mobile service and introduce disruptive and differentiating offers to our residential and business customers," said Boubazine. "Our expansion into the U.S. mobile industry is an exciting evolution for Altice USA, enabling us to deliver best-in-class entertainment and innovative digital services through high-quality, ubiquitous and seamless connectivity. We are making great progress readying our network infrastructure and customer management platforms to support our mobile offering and are glad to have Jean-Charles onboard for this next phase as we bring our wireless product to market."

12:00 EDT Oracle falls -7.3% - Oracle is down -7.3%, or -$3.36 to $42.91.

12:00 EDT Actuant rises 9.7% - Actuant is up 9.7%, or $2.52 to $28.48.

12:00 EDT Intelsat rises 21.4% - Intelsat is up 21.4%, or $3.44 to $19.50.

11:36 EDT OSI Systems receives $4M order for patient monitoring solutions - Before the market open, OSI Systems announced that its Healthcare division, Spacelabs Healthcare, received an order for approximately $4M to provide patient monitoring solutions and related accessories to a prominent U.S. hospital group. The company expects to install in FY19 its Xhibit Central Stations, Qube, Qube mini, and XTR Telemetry solutions for intensive care units (ICUs) at a new children's hospital currently under construction. The company did not disclose further details, citing end-user confidentiality obligations.

11:06 EDT Forward Industries subsidiary announces partnership with division of AB InBev - Intelligent Product Solutions (IPS), a subsidiary of Forward Industries (FORD), announced that it has partnered with ZX Ventures, a division of AB InBev (BUD), to design and develop an Internet "connected" beer vending machine that dispenses cans of cold beer, featuring a cashless payment system that accepts all major credit cards and mobile wallets. Called BeerBox, ZX Ventures plans to roll out these "first-of-a-kind connected 'bar-like' beer vending machines" later this year at select concert and sports venues nationwide, Forward stated in its announcement. Shares of Forward Industries are up 51c, or 36%, to $1.93 following the company's press release on the partnership.

11:02 EDT Deutsche Bank to pay $205M to settle New York forex probe - Financial Services Superintendent Maria T. Vullo announced that Deutsche Bank AG has agreed to pay a fine of $205M as part of a consent order with the New York State Department of Financial Services for violations of New York banking law, including efforts to improperly coordinate trading activity through online chat rooms, improperly sharing confidential customer information, trading aggressively to skew prices, and misleading customers. The violations announced stem from an investigation by DFS determining that from 2007 to 2013, when Deutsche Bank was the largest foreign exchange dealer in the world, the Bank repeatedly engaged in improper, unsafe, and unsound conduct in its foreign exchange business due to its failures to implement effective controls. In addition, for certain time periods, limited elements of Deutsche Bank's electronic trading platforms had the potential to improperly disadvantage customers and improperly affect markets, when certain applications did not perform as intended. The DFS investigation found that a number of Deutsche Bank foreign exchange traders participated in multi-party online chat rooms where participants shared confidential information, discussed coordinating trading activity, and attempted to manipulate foreign exchange currency prices or benchmark rates. By engaging in these activities, these traders sought to diminish competition and increase their profits by executing foreign exchange trades at the expense of customers or the wider market. The DFS investigation also discovered that certain Deutsche Bank employees sought to manipulate submission-based benchmarks for certain currency pairs. The DFS investigation also found that Deutsche Bank sales staff employed other tactics designed to secretly increase the "markup" charged to customers for trade execution. In a number of instances, Deutsche Bank staff intentionally failed to correct, or even intentionally made, errors or misleading entries in trade execution records so as to keep extra profit for themselves and the bank. Under the consent order, Deutsche Bank will take remedial actions to prevent the conduct from recurring and will submit plans to DFS to improve senior management oversight of the company's compliance with New York State laws and regulations relating to the company's foreign exchange trading business.

10:45 EDT Flexion seen benefiting from Anika Therapeutics' failed Cingal study - Shares of Flexion (FLXN) are on the rise after Anika Therapeutics (ANIK) announced that its Cingal Phase 3 trial did not demonstrate statistical significance versus steroid alone. Wells Fargo analyst David Maris believes this removes a potential threat from Flexion's Zilretta, which should have a clear runaway as it progresses through its early launch phase. CINGAL STUDY: Last night, Anika Therapeutics announced results from its CINGAL 16-02 clinical trial, an active-comparator Phase III study being conducted to support U.S. registration. Cingal has previously been evaluated in a placebo-controlled Phase III clinical trial that demonstrated safety and efficacy through 26-weeks. The 16-02 trial compared Cingal, a combination of cross-linked HA and triamcinolone hexacetonide, with TH alone and cross-linked HA in treating patients with osteoarthritis in the knee. The primary endpoint was a comparison of the pain reduction of Cingal compared with TH alone at 26-weeks. While Cingal achieved greater pain reduction numerically at every time point in the study, the difference at 26-weeks did not reach statistical significance. The patient response to Cingal in the study was strong, as significant improvements in pain, function and quality of life were observed at levels consistent with, and in most cases greater than, the results of the 13-01 placebo-controlled Phase III study of Cingal. A strong safety profile was also shown, matching previous clinical studies as well as real-world experience from growing product use globally. The duration of pain reduction was also similar to the previous study as patient improvement after Cingal injection was maintained near peak levels throughout the 26-week duration of the study. Follow-up of patients continues in a prospectively designed extension phase to the study, which will gather data through 39-weeks. MOVING TO THE SIDELINES ON ANIKA: Following the announcement, First Analysis analyst Joseph Munda downgraded Anika Therapeutics to Equal Weight from Overweight given the heightened level of uncertainty he sees for not only Cingal, but also for the other products in the pipeline, including Hyalofast, and the company's future go-direct strategy. The analyst told investors that he now thinks a 2019 approval for Cingal is now off the table. Despite management's comments regarding devising a plan to work with the FDA on the next steps to gain U.S. approval, Munda noted that it is not clear to him what that might entail. Ultimately, he thinks it will involve further clinical work, additional costs, and an extended timeline for approval. The analyst also lowered his price target on the shares to $34 from $45. His peer at Barrington also downgraded Anika Therapeutics to Market Perform from Outperform. Analyst Michael Petusky argued that it is difficult to imagine that the news will not weigh "heavy" on Anika shares, both today and for the foreseeable future. Further, the analyst now believes Cingal's commercial future in the U.S. is in "serious doubt." FLEXION TO BENEFIT: Also commenting on Anika's news, Wells Fargo analyst David Marris told investors in a research note that the failed Phase 3 study by the company's Cingal product in the treatment of knee osteoarthritis removes a potential threat from Flexion's Zilretta. With this competitor out of the way, the analyst believes the runway remains clear for Flexion, which is in the midst of the early phase of its launch of Zilretta. The drug's new unique J-code should become effective January 1 and should lead to "significant higher" sales, he contended. Marris reiterated an Outperform rating on Flexion shares. PRICE ACTION: In morning trading, shares of Flexion have gained almost 4% to $28.40, while Anika's stock has plunged over 35% to $29.68.

10:32 EDT Bank of Commerce Holdings raises quarterly cash dividend to 4c per share - Bank of Commerce Holdings announced that the Board of Directors has authorized a cash dividend of 4c per share for 2Q18, a 1c increase over the prior quarter. The 4c per share quarterly cash dividend will be paid to shareholders of record as of July 3, 2018 and is payable on July 13, 2018.

10:14 EDT Domino's Pizza sees domestic SSS up 3%-6% in 3-5 year outlook - As part of its three to five year outlook, Domino's sees global net units up 6%-8%, domestic same store sales up 3%-6%, international same store sales up 3%-6% and global retail sales up 8%-12%.

10:04 EDT Medtronic announces FDA 510(k) clearance for expanded bone cement indication - Medtronic announced the U.S. Food and Drug Administration has granted 510(k) clearance of Kyphon HV-R Bone Cement for fixation of pathological fractures of the sacral vertebral body using sacral vertebroplasty or sacroplasty. "This broadens Medtronic's commitment to treat fragility fractures beyond vertebral compression fractures caused by osteoporosis, cancer or benign lesions. With this expanded indication for Kyphon HV-R Bone, clinicians now have more options for treating patients with sacral insufficiency fractures," the company said.

10:00 EDT Navigator Holdings rises 11.2% - Navigator Holdings is up 11.2%, or $1.25 to $12.40.

09:47 EDT Globant falls -4.7% - Globant is down -4.7%, or -$2.67 to $54.33.

09:47 EDT Oracle falls -6.1% - Oracle is down -6.1%, or -$2.82 to $43.45.

09:47 EDT HUYA rises 6.8% - HUYA is up 6.8%, or $2.91 to $45.63.

09:34 EDT Johnson says 'not immune' to geopolitical events, focused on long-term in China - Starbucks CEO Kevin Johnson continues to be interviewed on CNBC.

09:30 EDT Amazon-Berkshire-JPMorgan healthcare joint venture names Atul Gawande CEO - Amazon (AMZN), Berkshire Hathaway (BRK.A, BRK.B) and JPMorgan Chase (JPM) announced the next step in their partnership on U.S. employee healthcare with the appointment of Atul Gawande as its CEO, effective July 9. The new company will be headquartered in Boston and will operate as an independent entity that is free from profit-making incentives and constraints. Gawande is a surgeon, writer and public health innovator. He practices general and endocrine surgery at Brigham and Women's Hospital and is Professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School. He is founding executive director of the health systems innovation center, Ariadne Labs. He also is a staff writer for The New Yorker magazine. "I'm thrilled to be named CEO of this healthcare initiative," said Gawande, "I have devoted my public health career to building scalable solutions for better healthcare delivery that are saving lives, reducing suffering, and eliminating wasteful spending both in the US and across the world. Now I have the backing of these remarkable organizations to pursue this mission with even greater impact for more than a million people, and in doing so incubate better models of care for all. This work will take time but must be done. The system is broken, and better is possible."

09:26 EDT Amazon, Berkshire, JPMorgan name Atul Gawande as CEO of new company

09:25 EDT S&P Global confirms purchase of RateWatch business from TheStreet - S&P Global (SPGI) announced that it is set to acquire the RateWatch business from TheStreet (TST). RateWatch, which was founded in 1989, was acquired by TheStreet in 2007. It will be integrated into S&P Global Market Intelligence, a division of S&P Global that provides essential intelligence for individuals, companies and governments through financial and industry data, research and news. Under the terms of the agreement, S&P Global will acquire from TheStreet all the assets comprising its RateWatch business for $33.5M in cash, subject to working capital and certain other customary adjustments. The deal was simultaneously signed and closed on the same day.

09:23 EDT Starbucks CEO says 'some canibalization,' new entrants hurt China SSS in Q3 - Starbucks CEO Kevin Johnson said Starbucks is "playing the long game" in China and the company's focus is transaction count growth. China same-store sales growth in Q3 was hurt by "some cannibalization" and from new entrants, said Johnson while being interviewed on CNBC.

09:19 EDT FireEye and Gigamon partner in security services - FireEye and Gigamon announced a global strategic partnership to improve threat defenses across their customers' security infrastructures. The alliance offers customers FireEye Network Security combined with the GigaSECURE Security Delivery Platform with flexible deployment options and scalability for threat protection.

09:10 EDT Exxon Mobil makes eighth oil discovery offshore Guyana - Exxon Mobil (XOM) said it made its eighth oil discovery offshore Guyana at the Longtail-1 well, creating the potential for additional resource development in the southeast area of the Stabroek Block. ExxonMobil encountered approximately 256 feet of high-quality, oil-bearing sandstone reservoir. The well was safely drilled to 18,057 feet depth in 6,365 feet of water. The Stena Carron drillship commenced drilling on May 25. ExxonMobil is currently making plans to add a second exploration vessel offshore Guyana in addition to the Stena Carron drillship, bringing its total number of drillships on the Stabroek Block to three. The new vessel will operate in parallel to the Stena Carron to explore the block's numerous high-value prospects. The Noble Bob Douglas is completing initial stages of development drilling for Liza Phase 1, for which ExxonMobil announced a funding decision in 2017. Phase 1 will consist of 17 wells connected to a floating production, storage and offloading, or FPSO, vessel designed to produce up to 120,000 barrels of oil per day. First oil is expected in early 2020. Phase 2 concepts are similar to Phase 1 and involve a second FPSO with production capacity of 220,000 barrels per day. A third development, Payara, is planned to follow Liza Phase 2. The Stabroek Block is 6.6M acres. Esso Exploration and Production Guyana Limited is operator and holds 45% interest in the Stabroek Block. Hess (HES) Guyana Exploration Ltd. holds 30% interest and CNOOC (CEO) Nexen Petroleum Guyana Limited holds 25% interest.

09:07 EDT Paratek Pharmaceuticals announces FDA advisory committee date for omadacycline - Paratek Pharmaceuticals announced that a meeting of the Antimicrobial Drugs Advisory Committee of the FDA has been scheduled for August 8, 2018 to review the Company's New Drug Applications, or NDAs, for once-daily, oral and intravenous omadacycline. Omadacycline is under review for the treatment of community-acquired bacterial pneumonia, or CABP, and acute bacterial skin and skin structure infections, or ABSSSI. The FDA accepted Paratek's NDA for priority review in April 2018. In the NDA acceptance letter, the FDA noted that it was planning to hold an advisory committee meeting. The target action date under the Prescription Drug User Fee Act is early October 2018.

09:05 EDT SunTrust made official bank of Atlanta International Airport - SunTrust Banks is now the official banking partner for Hartsfield-Jackson Atlanta International Airport. SunTrust recently received approval from the Atlanta City Council to open a branch, up to sixteen ATMs and one Teller Connect live video teller machine in the airport. Opening in 1Q19, the full-service branch will be located in the main domestic terminal while the ATMs will be available in the domestic and international concourses.

09:04 EDT Comtech awarded $1.4M from U.S. prime contractor - Comtech announced that during Q4, its Command & Control Technologies group, which is part of Comtech's Government Solutions segment, received an order for $1.4M from a U.S. Prime Contractor to provide spares for the SIPR/NIPR Access Point VSAT. The Command & Control Technologies group is a leading provider of mission-critical, highly-mobile C4ISR solutions.

09:02 EDT Envestnet's platform selected by Hancock Whitney Bank - Envestnet's platform has been selected by Hancock Whitney Bank to power both its broker-dealer and trust business lines. As part of the new integration, Hancock Whitney Bank plans to leverage Envestnet's automated compliance workflow for investment reviews, as well as enhanced fixed income portfolio management within a unified managed account structure. Hancock Whitney Bank began making Envestnet's services available to its advisors in late August 2017 and has since completed the initial implementation of the platform to both the bank's brokerage and trust divisions.

08:52 EDT On The Fly: Pre-market Movers - HIGHER: Class A shares of 21st Century Fox (FOXA), up 7% after Disney (DIS) raised its bid for the assets it had previously agreed to buy from the company. Disney shares are up about 1% following the news, while Comcast (CMCSA) Class A shares are also up fractionally... Synaptics (SYNA), up 10% after confirming merger talks with Dialog Semiconductor (DLGNF)... Tesaro (TSRO), up 7.5% after Spanish media group Intereconomia said that Roche (RHHBY) is working with Citibank on a potential acquisition of the cancer drug investigator. UP AFTER EARNINGS: Winnebago (WGO), up 11%. DOWN AFTER EARNINGS: Oracle (ORCL), down 4%... FedEx (FDX), down fractionally. ALSO LOWER: Anika Therapeutics (ANIK), down 18% after the company's Cingal Phase 3 trial did not demonstrate statistical significance versus steroid alone... Starbucks (SBUX), down 3.5% after announcing a strategy update and guidance reduction.

08:45 EDT Disney says does not have update on Sky, Fox 'in driver's seat'

08:42 EDT ABM, Oglethorpe County Schools initiate Energy Performance Contracting program - ABM has initiated an Energy Performance Contracting program for Oglethorpe County Schools in Lexington, Georgia. ABM's customized solution is projected to save Oglethorpe County Schools more than $9.4M in energy and operating costs over a 20-year period, which the school system will utilize to make facility upgrades, including the creation of a performing arts classroom at Oglethorpe County High School and improve its athletic facilities. The project launched on May 1, 2018, and is scheduled for completion in April 2019. Energy and operations savings will be achieved by implementing lighting and HVAC upgrades at each of the school system's facilities.

08:41 EDT Disney CEO: 'Even more confident in strategic fit' of Fox assets - Comments taken from Disney's (DIS) conference call discussing its sweetened bid for 21st Century Fox (FOXA) assets.

08:34 EDT NuVasive's PEEK spinal implant featured in Journal of Spine & Neurosurgery - NuVasive announced that the study "Early Outcomes of Anterior Cervical Discectomy and Fusion Using Porous PEEK Interbody Fusion Device," published online in the Journal of Spine & Neurosurgery, concludes that NuVasive patented porous polyetheretherketone - PEEK - technology is a clinically viable alternative for improving osseointegration and fusion rates of interbody implants to treat degenerative cervical disc disease. In the study, 50 patients with an average age of 60 with degenerative cervical disc disease underwent anterior cervical discectomy and fusion using a Cohere cervical interbody fusion device from NuVasive-with 100% of participants experiencing positive results. At 12 months post-operative ACDF surgery, all 50 patients demonstrated improved motion, decreased neck pain and average disc height increased by more than 4 mm. In addition, each of them showed radiographic fusion. NuVasive incorporated the technology into its portfolio with its acquisition of Vertera Spine in September 2017.

08:23 EDT LiveXLive Media's Slacker Radio partners with Dash Radio for content expansion - LiveXLive Media and Dash Radio, a digital radio broadcasting platform with more than 80 original live stations, have partnered to launch Dash channels across LiveXLive's subsidiary Slacker Radio, a streaming music and personalized radio subscription service. The introduction of Dash content marks the first time live radio is being made available across the Slacker platform.

08:17 EDT Nxt-IDs FitPay and Australia's Westpac extend contactless payment capabilities - NXT-ID's (NXTD) wholly owned subsidiary Fit Pay, a provider of payment, credential management, and authentication platform services and Westpac, Australia's oldest bank and company, and one of four major banking organizations in Australia and New Zealand, announced an agreement to extend contactless payment capabilities to a range of new devices, including the latest smartwatches from Garmin (GRMN). The Agreement enables Westpac customers to make secure contactless payments at NFC-enabled point-of-sale locations directly from Internet of Things and wearable devices that are integrated with the FitPay's Trusted Token Manager. Under the agreement, Westpac will participate in FitPay's Token Requester Program, which enables cardholders to add their payment credentials to devices that are integrated with FitPay's token management solution. The Platform powers the Garmin Pay capability on several recently launched smartwatches by Garmin.

08:15 EDT 21st Century Fox Class A shares up 5.5% after Disney raises bid for assets - Class A shares of 21st Century Fox (FOXA) are up $2.44, or about 5.5%, to $47.15 in pre-market trading after Disney (DIS) raised its bid for the assets it had previously agreed to buy from the company. Disney shares are down about 1% to $105.20 while Comcast (CMCSA) Class A shares are down 0.5%.

08:11 EDT Rupert Murdoch 'firmly' believes combination with Disney will unlock more value - "We are extremely proud of the businesses we have built at 21st Century Fox, and firmly believe that this combination with Disney will unlock even more value for shareholders as the new Disney continues to set the pace at a dynamic time for our industry. We remain convinced that the combination of 21CF's iconic assets, brands and franchises with Disney's will create one of the greatest, most innovative companies in the world," said Rupert Murdoch, Executive Chairman of 21st Century Fox.

08:10 EDT Disney boosts offer for 21st Century Fox assets to $38 per share - Twenty-First Century Fox (FOXA) announced that it has entered into an amended and restated merger agreement with Walt Disney (DIS) pursuant to which Disney has agreed to acquire for a price of $38 per 21CF share the same businesses Disney agreed to acquire under the previously announced merger agreement between 21CF and Disney. This price represents a "significant increase" over the purchase price of approximately $28 per share included in the Disney merger agreement when it was announced in December 2017. The amended and restated Disney merger agreement offers a package of consideration, flexibility and deal certainty enhancements that is superior to the proposal made by the Comcast Corporation (CMCSA) on June 13, Fox stated. Under the amended and restated Disney merger agreement, Disney would acquire those businesses on substantially the same terms, except that, among other things, Disney's offer allows 21CF stockholders to elect to receive their consideration, on a value equalized basis, in the form of cash or stock, subject to 50/50 proration. The collar on the stock consideration will ensure that 21st Century Fox shareholders will receive a number of Disney shares equal to $38 in value if the average Disney stock price at closing is between $93.53 and $114.32. In light of the revised terms contained in the amended and restated Disney Merger Agreement, 21CF's board, after consultation with its outside legal counsel and financial advisors, has not concluded that the unsolicited proposal it received on June 13, 2018 from Comcast could reasonably be expected to result in a "Company Superior Proposal" under the Disney merger agreement. However, the amended and restated Disney merger agreement contains no changes to the provisions relating to the company's directors' ability to evaluate a competing proposal. As announced on May 30, 2018, 21CF has established a record date of May 29, 2018 and a meeting date of July 10, 2018, for a special meeting of its stockholders to, among other things, consider and vote on a proposal to adopt the Disney merger agreement. 21CF has determined to postpone its special meeting of stockholders to a future date in order to provide stockholders the opportunity to evaluate the terms of Disney's revised proposal and other developments to date. Once 21CF determines the new date for 21CF's special meeting of stockholders, the date will be communicated to 21CF stockholders.

08:07 EDT Hudson announces 10-year concessions contract extension at BTV - Hudson announced the city of Burlington, Vermont has approved a 10-year concessions contract extension at Burlington International Airport, or BTV. As the incumbent retail concessionaire at BTV since 2003, the joint-venture agreement includes 3,182 square feet of retail space. Retail concepts represented in the extension include three Vermont eccentric travel essentials and convenience stores: Discover Vermont/Hudson, Lake Champlain News, and Mount Mansfield News.

08:06 EDT Choice Hotels to develop two new Cambria Hotels in South Carolina - Choice Hotels has signed two agreements with Four Raines to develop Cambria hotels in Greenville and Summerville, S.C., both rapidly growing business regions. The Cambria Hotel Greenville and the Cambria Hotel Summerville are both slated to open in October 2019.

08:05 EDT Teradata files suit against SAP - Teradata (TDC) filed a complaint in the U.S. District Court for the Northern District of California against SAP (SAP) for trade secret misappropriation, copyright infringement and antitrust violations. Highlights of Teradata's issued statement include: "Teradata is alleging that SAP has engaged in a decade-long campaign of anti-competitive behavior, to the detriment of the parties' customers and Teradata alike. SAP lured Teradata into a purported joint venture in order to gain access to Teradata's valuable intellectual property. SAP's purpose for the joint venture was to steal Teradata's trade secrets, developed over the course of four decades, and use them to quickly develop and introduce a competing though inferior product, SAP HANA. Upon release of SAP HANA, SAP promptly terminated the joint venture, and SAP is now attempting to coerce its customers into using HANA only, to the exclusion of Teradata. (...) Teradata is seeking an injunction barring SAP's illegal conduct, monetary damages, and all other legal and equitable relief available under law and which the court may deem proper. (...) The purpose of the joint venture - a purpose which Teradata now knows was a false one on SAP's part - was to combine SAP's ERP Applications suite and Business Warehouse reporting tool with Teradata's industry-leading "massively parallel processing" architecture for EDAW. (...) Moreover, and on information and belief, SAP has begun significantly restricting Teradata's ability to access customers' SAP-derived data. (...)"

08:03 EDT Genpact, Mondelez announce new multi-year agreement - Genpact (G) announced a new multi-year agreement with Mondelez (MDLZ). Building on a relationship that began in 2014 to transform Mondelez International's finance organization into a strategic growth lever, the expanded engagement allows the two companies to continue to co-innovate and drive faster, smarter insights from finance data. Genpact supports Mondelez International's global finance operations in 75 countries, delivering simplified and standardized operations across more than 150 finance and accounting processes.

08:01 EDT Evoqua Water agrees to acquire ProAct Services for $132M - Evoqua Water Technologies announced one of its wholly-owned subsidiaries has signed a definitive agreement to purchase ProAct Services Corporation, a provider of on-site treatment services of contaminated water in all 50 states from private equity firm Hammond, Kennedy, Whitney & Company Inc. and members of management, for $132M. Upon closing, ProAct Services will operate as a separate division within Evoqua's Industrial Segment and will continue to be based in Ludington, Michigan. The transaction is expected to close upon receipt of required regulatory approvals and satisfaction of customary closing conditions. Evoqua intends to finance the acquisition using an incremental $150M first lien term loan. The funds will be used to support this transaction, as well as to replenish the internally funded purchases of two recent acquisitions, and for general corporate purposes. Pro forma net leverage is expected to be approximately 3.6x following the transaction and financing.

07:48 EDT Kura Oncology plans to initiate trial of tipifarnib in 2H18 - Following a positive Phase 2 trial in HRAS mutant HNSCC and a successful end of Phase 2 meeting with the FDA, Kura is planning to conduct a global, registration-directed trial of its lead drug candidate tipifarnib in at least 59 recurrent or metastatic patients with HRAS mutant HNSCC, called the AIM-HN trial. The primary endpoint of the trial will be objective response rate. Based on feedback from the FDA, the company believes that the single-arm trial, if positive, could support an application for accelerated approval. Kura anticipates that AIM-HN will require fewer than 100 clinical sites worldwide and take approximately two years to enroll. The company expects to initiate the AIM-HN trial in the second half of 2018.

07:43 EDT TG Therapeutics, Novimmune enter global agreement to develop TG-1801 - TG Therapeutics and Novimmune announced that the companies have entered into an exclusive global agreement to collaborate on the development and commercialization of Novimmune's novel first-in-class anti-CD47/anti-CD19 bispecific antibody known as TG-1801. The companies will jointly develop the product on a worldwide basis, focusing on indications in the area of hematologic B-cell malignancies. TG Therapeutics will make up-front and milestones payments based on early clinical development, and will be responsible for the costs of clinical development of the products through the end of Phase II, after which TG Therapeutics and Novimmune will be jointly responsible for all development and commercialization costs of the product. TG Therapeutics and Novimmune will each maintain an exclusive option, exercisable at specific times during development, for TG Therapeutics to license the rights to TG-1801, in which case Novimmune will be eligible to receive additional payments contingent on certain clinical, regulatory and commercial milestones, totaling approximately $185M as well as tiered royalties on net sales. TG-1801, a fully-human IgG1, designed to target and deplete B-cells via multiple mechanisms, is based on Novimmune's kappa-lambda -body format which allows preservation of all favorable properties of a conventional monoclonal antibody while adding bispecific functionalities. One mechanism unique to this bispecific antibody involves blocking of CD47 referred to as the "do not eat me" signal for the body's phagocytic cells specifically directed to CD19 positive cells. The net effect is highly targeted, potent anti-B-cell tumor phagocytic activity, while avoiding the general toxicity concerns associated with earlier agents targeting the CD47 pathway. Moreover, the co-targeting of CD19 is not only expected to enhance safety but by retaining its IgG1 Fc functionality, this agent is designed to provide a secondary mechanism of anti-tumor activity through the induction of antibody dependent cellular cytotoxicity. TG-1801 is expected to be the first anti-CD47 bispecific antibody worldwide that will go into clinical trials, which are expected to commence later this year or early in 2019.

07:38 EDT FirstService announces acquisitions made by Century Fire Protection - FirstService announced that its subsidiary, Century Fire Protection, has recently acquired two Georgia-based fire protection service companies, ASA Fire Protection and Swift Fire Protection. The leaders of both businesses will continue to run day-to-day operations. Terms of the transactions were not disclosed.

07:34 EDT Neovasc's Reducer implanted in first U.S. Patient - Neovasc announced the first U.S. patient has been implanted with a Neovasc Reducer, a CE-Marked medical device for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary arteries deliver an inadequate supply of blood to the heart muscle. The Compassionate Use case was conducted at Henry Ford Hospital in Detroit, Michigan. The Reducer provides relief of angina symptoms by altering blood flow in the heart's circulatory system, thereby increasing the perfusion of oxygenated blood to ischemic areas of the heart muscle.

07:06 EDT Delta Air Lines orders 20 Bombardier CRJ900 valued at approx. $961M - Bombardier Commercial Aircraft (BDRBF) announced that Delta Air Lines (DAL) of Atlanta, Georgia has signed a firm purchase agreement for 20 CRJ900 aircraft - becoming the launch operator of the new ATMOSPHERE cabin for CRJ Series regional jets.Based on the list price for the CRJ900 aircraft, the firm order is valued at approximately $961M The new CRJ900 aircraft with ATMOSPHERE cabin will fly under the Delta Connection brand in a comfortable two-class regional jet configuration with 70 seats. Delta Air Lines will take delivery of the world's first ATMOSPHERE cabin CRJ900 aircraft in late 2018. Including the order form Delta Air Lines, Bombardier has recorded firm orders for 1953 CRJ Series aircraft.

07:03 EDT Amneal announces patent litigation settlement agreement with Actavis - Amneal Pharmaceuticals announced that it has entered into a settlement agreement with Actavis Laboratories and Actavis Pharma resolving patent litigation related to Rytary. The litigation has been pending in the U.S. District Court for the District of New Jersey and resulted from Actavis's submission of an Abbreviated New Drug Application to the U.S. Food & Drug Administration seeking approval to market a generic version of Rytary. Under the terms of the agreement, Amneal will grant Actavis a license to begin selling a generic version of Rytary on July 31, 2025, or earlier under certain circumstances. Additional details regarding the settlement were not disclosed. The launch of Actavis's generic product is contingent upon Actavis receiving final approval from the FDA of its ANDA for a generic version of Rytary. As required by law, the parties will submit the settlement agreement to the U.S. Federal Trade Commission and the U.S. Department of Justice for review. Patent infringement litigations brought by Sandoz, Zydus Pharmaceuticals USA and Cadila Healthcare, related to each company's proposed generic version of Rytary remain pending in the U.S. District Court for the District of New Jersey.

07:02 EDT IDC: Worldwide shipments of AR, VR headsets down 30.5% in Q1 to 1.2M units - Worldwide shipments of augmented reality and virtual reality headsets were down 30.5% year over year, totaling 1.2 million units in the first quarter of 2018, according to the International Data Corporation Worldwide Quarterly Augmented and Virtual Reality Headset Tracker. Much of the decline occurred due to the unbundling of screenless VR headsets during the quarter. For much of 2017, vendors bundled these headsets free with the purchase of a high-end smartphone, but that practice largely came to an end by the start of 2018. Despite a poor start to 2018, IDC anticipates the overall market will return to growth over the remainder of the year as more vendors target the commercial AR and VR markets and low-cost standalone VR headsets such as the Oculus Go make their way into stores. IDC forecasts the overall AR and VR headset market to grow to 8.9 million units in 2018, up 6% from the prior year. That growth will continue throughout the forecast period, reaching 65.9 million units by 2022. "On the VR front, devices such as the Oculus Go seem promising not because Facebook has solved all the issues surrounding VR, but rather because they are helping to set customer expectations for VR headsets in the future," said Jitesh Ubrani senior research analyst for IDC Mobile Device Trackers. "Looking ahead, consumers can expect easier-to-use devices at lower price points. Combine that with a growing lineup of content from game makers, Hollywood studios, and even vocational training institutions, and we see a brighter future for the adoption of virtual reality." Publicly traded companies in the AR and VR space include Facebook (FB), Samsung (SSNLF), Alphabet (GOOG, GOOGL), Apple (AAPL), HP (HPQ) and Lenovo (LNVGY). Reference Link

07:01 EDT JinkoSolar supplies 275.4 MWdc solar moduals to Green Light Contractors - JinkoSolar Holding announced that it has supplied 275.4 MWdc of high efficiency modules to Green Light Contractors Pty Ltd for use in the Bungala Solar Farm near Port Augusta, South Australia, which is owned by a joint venture between Enel Green Power and Dutch Infrastructure Fund. Green Light Contractors, a subsidiary of Elecnor Group is EPC contractor for the the Bungala project, which recently completed and started production at its first 137.7 MWdc phase. The Bungala project is the largest solar PV project under construction in Australia.

06:45 EDT Hyundai, Audi announce partnership in fuel cell technology - Hyundai Motor Group (HYMTF) and AUDI AG (AUDVF) announced they have entered into a multi-year patent cross-licensing agreement, covering a broad range of fuel cell electric vehicle components and technologies. Under the new partnership, the world's fifth-largest auto-making group and the German premium car maker will make joint efforts in developing FCEVs, to lead the automotive industry to a more sustainable future. The cross-license agreement has been signed between Hyundai Motor Company - the Group's flagship car-making unit - and Audi but also covers and benefits both companies' affiliates, including but not limited to Kia Motors Corporation and Audi's parent company Volkswagen AG (VLKAY). Hyundai and Audi, as well as their affiliates will equally share the patent licenses over the years to come. The duration of the agreement has not been disclosed. The agreement also includes mutual access to fuel cell components. As a first step, Hyundai Motor Group will grant its counterpart the access to parts that are based on Hyundai's know-how accumulated from the development of ix35 Fuel Cell as well as NEXO. Audi - responsible for the development of fuel cell technology within the Volkswagen Group - will also be able to take full advantage of Hyundai's FCEV parts supply chain. Hyundai Motor Company, the world's first mass-producer of fuel cell vehicles, has been offering SUV-Class FCEVs since 2013, and currently sells them in 18 countries around the world.

06:35 EDT Horizon Global provides update on performance, status of action plan - Horizon Global provided a revised business outlook and an update on its Action Plan, including actions to improve performance in its Americas and Europe-Africa segments."I have been closely involved with the operational challenges and related solutions in the Americas since late January of this year, and I have spent the past month evaluating our global operations and meeting with the management teams of each business segment," said Carl Bizon, Interim President and CEO of Horizon Global. "Following this initial evaluation, I am pleased to confirm there are many underlying strengths of our Company - Horizon Global has excellent brands, a loyal customer base, experienced and committed team members, excellent quality and solid end markets. These foundational strengths support my confidence in the long-term success of Horizon Global. However, my initial evaluation of our global operations highlighted a number of near-term operational issues that must be addressed promptly. In March, we announced a series of immediate and longer-term steps to improve performance, which are now part of the Company's overall Action Plan. We have identified additional initiatives, primarily in Europe-Africa, to expand the Action Plan and ensure that the Company is moving in a positive direction. A good deal of my leadership experience includes fixing operational issues within companies, and I am pleased to report that the issues I see today at Horizon Global are operational in nature, not structural. We are taking swift action, with the support of our Board of Directors, to address these operational challenges, including leadership changes in the Americas and Europe-Africa segments and a renewed focus on integrated business planning processes to align our global team and prioritize operational initiatives. Additionally, we recently announced the termination of the Brink Group acquisition. While the Company firmly believed in the rationale underlying the acquisition, terminating the agreement is currently in the best interests of the Company and allows complete management focus on our existing business. Absolute attention to our operations, core brands, customers and distribution channels is necessary at this time." Commented David Rice, CFO of Horizon Global, "Although we are making solid progress against our Action Plan initiatives in the Americas related to restructuring and consolidating the organization, the delayed financial realization of our operational improvements and persistent headwinds in Europe-Africa are expected to result in performance that is below our expectations in the quarter. In response to these challenges, we are tightly managing discretionary and non-core SG&A expenses across the organization. While we did not provide guidance for the second quarter, we expect our upcoming quarterly results to fall below current analyst consensus. In spite of showing steady improvement through much of the second quarter, our Kansas City distribution center did not begin approaching its daily shipment goals until well into the month of June. As such, we are expecting to exit the second quarter with more that $20 million in past-due orders. Additionally, we expect that the performance of our Europe-Africa segment relative to our expectations, as well as the further decline in our market capitalization as compared to the end of the first quarter, will trigger the need to perform an interim impairment test of goodwill and other intangible assets, which may result in an additional non-cash impairment." Horizon Global announced a business improvement plan on March 1, 2018 with targeted initiatives to drive operating results in each of its business segments. Action Plan updates include: Reynosa production facility performing at desired production levels with process improvements well established under new leadership; Kansas City average daily shipments increased over 70 percent from start of second quarter through late June; Americas consolidation and organizational delayering is on track with 90 percent completion expected by the end of Q2; new leadership in the areas of sales, engineering, distribution and manufacturing; Europe-Africa low-cost-country production increased 59 percent year to date; After the recent evaluation of Horizon's global operations, the following actions have been added to the Action Plan: Jason Kieseker named President of Europe-Africa, maintaining responsibility for Asia-Pacific with support of new general manager for the region; Newly created position for Vice President of Operations for Europe-Africa; New leadership and process improvements in Europe-Africa to alleviate over-reliance on third-party consultants.

06:31 EDT Horizon Global withdraws previous FY18 guidance - CEO Carl Bizon said, "We fully grasp the magnitude of the work we have ahead of us. Given our focus on correcting the operational issues facing Horizon Global, we believe it is appropriate to withdraw our previous financial guidance for full year 2018. The decision to withdraw our guidance in no way takes away from our commitment to move quickly to deliver improved performance. We have not lost sight of and remain committed to our longer-term financial goals for our business. Although it may take longer than we planned, we believe that our long-term goals of 3- to 5-percent revenue growth and 10-percent operating margins are achievable. We will continue to update investors on our progress against achieving our operating and process improvement goals and will re-evaluate our approach to annual guidance in the future."

06:02 EDT National Health Investors acqiures two Michian communities for $17.1M - National Health Investors purchased Bavarian Comfort Care, a 51-unit assisted living and memory care community located in Bridgeport, Michigan, and Shield Comfort Care, a 53-unit assisted living and memory care facility located in Saginaw, Michigan, for $17.1M. The communities were acquired from and will be leased to affiliates of a new partner, Comfort Care Senior Living, at an average yield of 8.1% with CPI-based escalators. NHI will also have a purchase option on two additional communities in Michigan. Founded in 2013, Comfort Care is an owner, operator and developer of assisted living and memory care communities based in Saginaw, Michigan.

05:56 EDT Telstra plans to cut 8,000 jobs in new Telstra2022 strategy - Telstra announced a new strategy to "lead the Australian market by simplifying its operations and product set, improving customer experience and reducing its cost base. The strategy, named Telstra2022, has four key pillars: Radically simplify our product offerings, eliminate customer pain points and create all digital experiences; Establish a standalone infrastructure business to drive performance and set up optionality post the nbn rollout; Greatly simplify our structure and ways of working to empower our people and serve our customers; Industry leading cost reduction programme and portfolio management." The strategy includes: "Creation of a new wholly owned infrastructure business unit, 'InfraCo' to drive performance and provide future optionality for a demerger or the entry of a strategic investor in a post-nbn rollout world; Radical transformation of customer plans and pricing to deliver improved customer experience; Increase of our productivity program by a further $1 billion to $2.5 billion cost out by FY22; 8,000 net reduction in employees and contractors and reduction in 2-4 layers of management; Monetisation of up to $2 billion in assets over the next two years to strengthen the balance sheet; Telstra to remain premium brand and lead and win in 5G; FY19 EBITDA guidance of $8.7 - $9.4 billion expected excluding restructuring costs of approximately $600 million." Telstra CEO Andrew Penn said "The rate and pace of change in our industry is increasingly driven by technological innovation and competition. In this environment traditional companies that do not respond are most at risk. We have worked hard preparing Telstra for this market dynamic while ensuring we did not act precipitously. However, we are now at a tipping point where we must act more boldly if we are to continue to be the nation's leading telecommunications company."

05:48 EDT CBRE Group to acquire majority interest in Ramot Group - CBRE Group announced that it has entered into an agreement to acquire a majority interest in the Ramot Group, a facilities management provider in Israel. Founded by Shlomo Margolin in 1993, Ramot, based in Tel Aviv, employs more than 750 staff and manages an extensive portfolio of facilities. Ramot's substantial capabilities include technical maintenance, project management, cleaning services, reception administration and environmental health and safety. The Ramot Group will operate as part of CBRE's Global Workplace Solutions business in Israel and adds an extensive suite of integrated facilities management and specialist technical capabilities for local and international clients. CBRE has a long-established relationship with Ramot, which has been a service provider to some of its corporate clients in Israel since 2009. The Ramot acquisition is subject to customary regulatory approvals and is expected to close in the third quarter of 2018.

05:13 EDT Microsoft announces plans to expand cloud computing investment in Europe - Microsoft on Wednesday announced plans to further expand its significant and growing investment in cloud computing in Europe by delivering the intelligent Microsoft Cloud from two new datacenter regions in Norway: one in the greater Stavanger region and the other in Oslo. The Microsoft Cloud, comprising Microsoft Azure, Office 365 and Dynamics 365, will offer enterprise-grade reliability and performance with data residency from new datacenter locations. Initial availability of Azure is planned for late 2019 with Office 365 and Dynamics 365 to follow. Microsoft has deep expertise protecting data, championing privacy, and empowering customers around the globe to meet extensive security and privacy requirements with Microsoft's Trusted Cloud principles and the broadest set of compliance certifications and attestations in the industry.